Selective Retrograde Venography and Sclerotherapy of Internal Spermatic Veins and Associated Venous Bypasses and Retro-Peritoneal Collateral in Patients With Bilateral Varicocele and Localized Prostate Cancer
N/A
45 Years
75 Years
45 Years
75 Years
Not Enrolling
Male
Prostate Cancer
Male
Prostate Cancer
Trial Information
Selective Retrograde Venography and Sclerotherapy of Internal Spermatic Veins and Associated Venous Bypasses and Retro-Peritoneal Collateral in Patients With Bilateral Varicocele and Localized Prostate Cancer
Inclusion Criteria:
- Males age 45-75
- Prostate cancer
- Presence of varicocele
- No contraindication for venography
Exclusion Criteria:
- Diseases or medications which prevent interventional vascular procedures
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Safety performance of the procedure. The change in tumor size and prostate cancer cells as evaluated by trans-rectal ultrasound and prostate biopsy
Outcome Time Frame:
one year
Safety Issue:
Yes
Authority:
Israel: Ministry of Health
Study ID:
RVS-002-IL
NCT ID:
NCT00637208
Start Date:
November 2007
Completion Date:
March 2008
Related Keywords:
- Prostate Cancer
- prostate cancer
- venography
- male patients
- Localized microscopic prostate cancer up to Gleason 6 (3+3)
- PSA level <14
- presence of varicocele
- Prostatic Neoplasms
- Varicocele
Name | Location |
|---|
